Reason for request
Re-assessment of the Actual Benefit and Renewal of inclusion
Clinical Benefit
| Low |
The actual benefit of the NORMISON proprietary medicinal products is low in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia. " |
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
Ja8CYKDmwgvX5DbM
